Quantcast

Latest Alzheimer's disease clinical research Stories

2014-05-23 08:24:08

BOSTON, Mass., May 23, 2014 /PRNewswire/ -- AZTherapies, Inc. a company developing novel treatments for Alzheimer's disease based on technology licensed from Massachusetts General Hospital, announced that it has received notice from FDA that it may proceed with the Phase III clinical study submitted in its IND application. This study is for its lead program, ALZT-OP1, a novel combination therapy for the prevention and treatment of early Alzheimer's disease. ALZT-OP1 is a...

2014-04-14 12:32:55

Researchers recruiting patients with mild to moderate Alzheimer's disease to participate in six week study SUN CITY, Ariz., April 14, 2014 /PRNewswire/ -- Banner Sun Health Research Institute is proud to announce it is one of just five facilities in the United States to launch a new clinical trial for patients with mild to moderate Alzheimer's disease (AD). This study, titled "Effect of NeuroAD(TM), Combined TMS Stimulation and Cognitive Training, on the cognitive function of mild to...

Researchers Quantify Brain Protein Changes In Alzheimer Patients
2013-06-13 08:30:44

April Flowers for redOrbit.com - Your Universe Online A significant and potentially pivotal difference between the brains of patients with an inherited form of Alzheimer's disease and healthy family members who do not have it has been measured by researchers at Washington University School of Medicine in St. Louis. Researchers have long known that a protein fragment called amyloid beta builds up into plaques in Alzheimer´s patient´s brains. The theory is that these plaques...

2013-05-15 23:03:02

MetLife Foundation today announced the recipients of its 2013 Awards for Medical Research in Alzheimer´s Disease: Yueming Li, Ph.D., member and professor, Sloan-Kettering Institute and director and professor, Graduate Program in Pharmacology, Weill Medical College of Cornell University, and Lennart Mucke, M.D., director, Gladstone Institute of Neurological Disease, Joseph B. Martin Distinguished Professor of Neuroscience and professor of Neurology, University of California, San...

shutterstock_101520898
2012-08-07 20:35:06

Michael Harper for redOrbit.com - Your Universe Online After another failed high-profile clinical trial, pharmaceutical companies Pfiizer Inc and Johnson & Johnson have said they´ve halted research and development of bapineuzumab, a drug which could have been used in patients with mild to moderate Alzheimer's disease. According to Reuters, both drug makers have said they´ll discontinue their studies of bapineuzumab in its intravenous (IV) form. Two late stage trials and...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.